2,752 reports of this reaction
5.9% of all OXAZEPAM reports
#1 most reported adverse reaction
TOXICITY TO VARIOUS AGENTS is the #1 most commonly reported adverse reaction for OXAZEPAM, manufactured by Actavis Pharma, Inc.. There are 2,752 FDA adverse event reports linking OXAZEPAM to TOXICITY TO VARIOUS AGENTS. This represents approximately 5.9% of all 46,840 adverse event reports for this drug.
Patients taking OXAZEPAM who experience toxicity to various agents should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TOXICITY TO VARIOUS AGENTS is moderately reported among OXAZEPAM users, representing a notable but not dominant share of adverse events.
In addition to toxicity to various agents, the following adverse reactions have been reported for OXAZEPAM:
The following drugs have also been linked to toxicity to various agents in FDA adverse event reports:
TOXICITY TO VARIOUS AGENTS has been reported as an adverse event in 2,752 FDA reports for OXAZEPAM. This does not prove causation, but indicates an association observed in post-market surveillance data.
TOXICITY TO VARIOUS AGENTS accounts for approximately 5.9% of all adverse event reports for OXAZEPAM, making it one of the most commonly reported side effect.
If you experience toxicity to various agents while taking OXAZEPAM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.